TENX
Tenax Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.60 / 10
Outperform
Analyst sentiment is overwhelmingly bullish (Strong Buy 100 %), yet the fund-flow profile shows positive momentum in large-size categories but negative in small and medium, hinting at institutional accumulation versus retail caution; overall, the analyst and money-flow assessment leans positive but is tempered by the neutral technical backdrop.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-17
InstitutionGuggenheim
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for TENX?
- TENX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.60/10 (Outperform).
